Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023
Source:
Nasdaq GlobeNewswire
/
23 Oct 2023 08:07:01 America/New_York
N/A
Share on,